RCW 70.225.070
Requirements for test sites in the prescription monitoring program.
(1) Test sites that may receive access to data in the prescription monitoring program under RCW 70.225.040 must be:
(a) Licensed by the department as a test site under chapter 70.42 RCW; and
(b) Certified as a drug testing laboratory by the United States department of health and human services, substance abuse and mental health services administration.
(2) Test sites may not:
(a) Charge a fee for accessing the prescription monitoring program;
(b) Store data accessed from the prescription drug monitoring program in any form, including, but not limited to, hard copies, electronic copies, or web/digital based copies of any kind. Such data may be used only to transmit to those entities listed in *RCW 70.255.040(3)(a).
[ 2015 c 259 § 2.]
NOTES:
*Reviser's note: The reference to RCW 70.255.040 appears to be erroneous. RCW 70.225.040 was apparently intended.
Structure Revised Code of Washington
Title 70 - Public Health and Safety
Chapter 70.225 - Prescription Monitoring Program.
70.225.020 - Prescription monitoring program—Subject to funding—Duties of dispensers.
70.225.030 - Enhancement of program—Feasibility study.
70.225.050 - Department may contract for operation of program.
70.225.060 - Violations—Penalties—Disclosure exemption for health care providers.
70.225.070 - Requirements for test sites in the prescription monitoring program.
70.225.080 - Access to data in the qualifying laboratory.
70.225.090 - Integration with certified electronic health record technologies.